Newfound Research’s CVS Health CVS Stock Holding History

Newfound Research’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-11	Closed	-$1K	–	79
2020 Q1	$1K	Hold	11	–	–	﹤0.01%	56
2019 Q4	$1K	Sell	11 -6	-35%	-$421	﹤0.01%	100
2019 Q3	$1K	Buy	17 +1	+6%	+$59	﹤0.01%	113
2019 Q2	$1K	Hold	16	–	–	﹤0.01%	109
2019 Q1	$1K	Hold	16	–	–	﹤0.01%	107
2018 Q4	$1K	Hold	16	–	–	﹤0.01%	91
2018 Q3	$1K	Hold	16	–	–	﹤0.01%	129
2018 Q2	$1K	Hold	16	–	–	﹤0.01%	117
2018 Q1	$1K	Sell	16 -1	-6%	-$72	﹤0.01%	114
2017 Q4	$1K	Hold	17	–	–	﹤0.01%	129
2017 Q3	$1K	Buy	17 +1	+6%	+$79	﹤0.01%	126
2017 Q2	$1K	Hold	16	–	–	﹤0.01%	124
2017 Q1	$1K	Hold	16	–	–	﹤0.01%	125
2016 Q4	$1K	Sell	16 -1	-6%	-$81	﹤0.01%	103
2016 Q3	$2K	Sell	17 -1	-6%	-$94	﹤0.01%	86
2016 Q2	$2K	Buy	+18	New	+$1.79K	﹤0.01%	80

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Newfound Research's CVS Position: Q2 2020 in Review

Newfound Research sold out of CVS Health (CVS) in Q2 2020, closing a stake of 11 shares — an estimated $1K sold.

Newfound Research first reported a position in CVS in Q2 2016 and held it in 16 quarters. The position peaked at $2K in Q3 2016. 1,863 funds tracked by Wall St. Rank hold CVS as of Q2 2020.

Newfound Research reported no remaining CVS Health position as of Q2 2020 after selling out during the quarter.
Newfound Research sold 11 CVS Health shares in Q2 2020, an estimated $1K.
Newfound Research first reported a position in CVS Health in Q2 2016 and held it in 16 quarters.
Newfound Research's CVS Health position peaked at $2K in Q3 2016.
1,863 funds tracked by Wall St. Rank held CVS Health as of Q2 2020.

Based on Newfound Research's 13F filing for Q2 2020, filed 10 Aug 2020.